Super Chinese Nephrotic Syndrome Registration System (SUCCESS)

NCT03001934 · tracked via the Priya Life Science China tracker

Sponsor

Sun Yat-sen University

Phase

Observational

Started

2016-04

Last updated

2026-09-15

Condition(s) studied

Nephrotic Syndrome

Investigational drug(s) / intervention(s)

No intervention

No intervention: Registration of all NS patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals which have signed the contract in China.

Study summary

The investigators are registering all nephrotic syndrome (NS) patients regardless of the primary causes and developing a NS database in China. Patients will be followed-up and both baseline and follow-up information will be recorded in the registration system. The treatment response, longitudinal changes of renal function, renal survival, patient survival, infection events and acute kidney injury etc, will be analyzed using the NS database.

Eligibility

Sex

ALL

Min age

14 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Nephrotic syndrome patients regardless of the primary causes Exclusion Criteria: * No

Primary outcome measure(s)

The patient survival in NS patients — 10 years

Trial sites (1)

Facility	City	Region	Status
The 1st Affiliated Hospital, Sun Yet-sen University	Guangzhou	Guangdong	Recruiting

More Sun Yat-sen University trials in China

SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx Recruiting

Esthetic, Clinical and Radiographic Outcomes of Immediate and Delayed Implant Placement Recruiting

Efficacy of Trastuzumab Deruxtecan in Metastatic Breast Cancer With Different HER2 Expression Patterns Recruiting

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial Recruiting

Evaluation of Impedance Cardiography for Assessing Hemodynamic Shifts in Patients With LA-NSCLC During Treatment. Active, not recruiting

Other trials for the same condition

Steroid Diabetes in Patients With Kidney Disease Recruiting

The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome. Active, not recruiting

Clinical Follow-up Study of Rituximab in the Treatment of Nephrotic Syndrome in Children Recruiting

Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03001934 on ClinicalTrials.gov ↗ ← All trials in China